Pacific Shuanglin Bio-pharmacy: Pre-disclosure announcement of the shareholding reduction plan by shareholders holding more than 5% and some directors.
Pacific Shuanglin Bio-pharmacy: Announcement regarding the cancellation of expired and unexercised stock options.
Pacific Shuanglin Bio-pharmacy: Legal opinion of Jia Yuan Law Firm, Peking, on the cancellation of the 2020 stock options and restrictive stock incentive plan of Paz Pharmaceutics Co., Ltd. that have expired but not yet exercised.
Pacific Shuanglin Bio-pharmacy: Announcement on the Implementation of Profit Distribution for the Year 2023.
Pacific Shuanglin Bio-pharmacy: Announcement on the release of pledge of shares by company shareholders.
Pacific Shuanglin Bio-pharmacy: Announcement on the completion of the share reduction plan for shareholders holding 5% or more of the shares
Pacific Shuanglin Bio-pharmacy: Announcement on the 2023 Profit Distribution Plan
Pacific Shuanglin Bio-pharmacy: Opinions of Guotai Junan Securities Co., Ltd. on the fulfillment of the 2023 performance promise of Paisi Shuanglin Biopharmaceutical Co., Ltd. to issue shares and pay cash to purchase assets and raise supporting capital and related transactions (2)
Pailin Biotech: Announcement on the Company's shareholders' stock pledge repurchase transactions
Pailin Biotech: Pre-disclosure Notice on Plans to Reduce Shareholdings by Shareholders Holding 5% or More
Pailin Biotech: Guotai Junan Securities Co., Ltd.'s inspection opinion on the lifting of the ban on some restricted shares issued by Paisi Shuanglin Biopharmaceutical Co., Ltd. and the payment of cash to purchase assets and raise supporting capital and rel
Pailin Biotech: An indicative announcement on the listing and circulation of some restricted shares
Pailin Biotech: Announcement on the completion of the cancellation of some restricted stock repurchases
Pailin Biotech: Announcement on the completion of the implementation of the plan for the controlling shareholder of the company, Mr. Shen Heping, to increase his shareholding in the company
Pailin Biotech: Announcement on the plan of Mr. Shen Heping, the company\'s largest shareholder and concerted actor, to increase the company\'s share holdings
Pailin Biotech: Independent Director\'s Independent Opinion on Price Adjustments Related to 2020 Stock Options and Restricted Stock Incentive Plans
Pailin Biotech: Supervisory Board\'s Review Opinions on Price Adjustments Related to 2020 Stock Options and Restricted Stock Incentive Plans
Pailin Biotech: Announcement on price adjustments related to stock options and restricted stock incentive plans in 2020
Pailin Biotech: Legal opinion from Beijing Jiayuan Law Firm on price adjustments related to Paisu Shuanglin Biopharmaceutical Co., Ltd.\'s 2020 stock options and restricted stock incentive plan
Pailin Biotech: Announcement on the Expiration of the Share Repurchase Period and the Implementation Results of the Share Repurchase
No Data